BioCorRx (BICX) Short Interest Ratio & Short Volume

Short interest is the volume of BioCorRx shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 2,200 shares of BICX short. Learn More on BioCorRx's current short interest.

BioCorRx saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 2,200 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "healthcare" compare to BioCorRx: Concord Medical Services Holdings Limited (0.19%), American Shared Hospital Services (0.85%), Kindly MD, Inc. (2.50%), PharmChem, Inc. (0.00%), BioRestorative Therapies, Inc. (4.64%), Mangoceuticals, Inc. (3.06%), Xcelerate Inc. (0.00%), Pacific Health Care Organization, Inc. (0.01%), Ontrak, Inc. (2.50%), Vsee Health, Inc. (1.84%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling BICX is an investing strategy that aims to generate trading profit from BioCorRx as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioCorRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BICX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BICX, twice per month. The most recent reporting period available is January, 31 2025.